Infarction Clinical Trials

368 recruitingLast updated: July 25, 2026

There are 368 actively recruiting infarction clinical trials across 51 countries. Studies span Not Applicable, Phase 4, Phase 3, Phase 2, Early Phase 1, Phase 1. Top locations include Seoul, South Korea, Beijing, Beijing Municipality, China, London, United Kingdom. Updated daily from ClinicalTrials.gov.


Infarction Trials at a Glance

368 actively recruiting trials for infarction are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 137 trials, with the heaviest enrollment activity in Seoul, Beijing, and London. Lead sponsors running infarction studies include Assistance Publique - Hôpitaux de Paris, National Institute of Cardiovascular Diseases, Pakistan, and Queen Mary University of London.

Browse infarction trials by phase

Treatments under study

About Infarction Clinical Trials

Looking for clinical trials for Infarction? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Infarction trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Infarction clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 368 trials

Recruiting
Not Applicable

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Heart FailureCardiogenic ShockAcute Myocardial Infarction (AMI)
Magenta Medical Ltd.10 enrolled8 locationsNCT07293923
Recruiting
Phase 3

Ivabradine in the Acute Management of Cardiogenic Shock

Cardiogenic Shock Post Myocardial Infarction
National Institute of Cardiovascular Diseases, Pakistan200 enrolled1 locationNCT07714746
Recruiting
Not Applicable

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

Acute Myocardial Infarction (AMI)ST-segment elevation myocardial infarction (STEMI)Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University2,000 enrolled48 locationsNCT07567625
Recruiting
Not Applicable

The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

Myocardial Infarction
Yuzuncu Yil University50 enrolled1 locationNCT07696390
Recruiting
Phase 2

A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction

Acute Anterior ST-Segment Elevation Myocardial Infarction
Beijing Sungen Biomedical Technology Co., Ltd210 enrolled1 locationNCT07306182
Recruiting

Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

STEMI - ST Elevation Myocardial Infarction
Firat University500 enrolled2 locationsNCT07689591
Recruiting
Phase 2Phase 3

Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

STEMI - ST Elevation Myocardial Infarction
Oxford University Hospitals NHS Trust60 enrolled1 locationNCT07687576
Recruiting
Not Applicable

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Spinal Cord Injuries (SCI)Amyotrophic Lateral Sclerosis(ALS)Muscular Dystrophies+6 more
Johns Hopkins University5 enrolled1 locationNCT07521930
Recruiting
Phase 2

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

Myocardial InfarctionSTEMI (ST Elevation MI)Reperfusion Injury+1 more
Nyrada Pty Ltd300 enrolled7 locationsNCT07362446
Recruiting
Not Applicable

Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study

Myocardial Infarction
University of Edinburgh19,500 enrolled3 locationsNCT07636642
Recruiting

Early Identification and Diagnosis of BAD-related Stroke

Acute Ischemic StrokeCerebral InfarctionBranch Atheromatous Disease
Peking Union Medical College Hospital1,602 enrolled11 locationsNCT07693816
Recruiting
Not Applicable

Timing of FFR-guided PCI for Non-IRA in NSTEMI and MVD (OPTION-NSTEMI)

Myocardial Infarction, AcuteMulti Vessel Coronary Artery DiseaseMulti-Vessel Coronary Artery Stenosis
Chonnam National University Hospital1,014 enrolled1 locationNCT04968808
Recruiting
Phase 4

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Dual Antiplatelet TherapyST Elevated Myocardial Infarction
Research Maatschap Cardiologen Rotterdam Zuid1,656 enrolled27 locationsNCT05491200
Recruiting
Not Applicable

Transcultural Digital Solutions in Phase III Cardiac Rehabilitation

Heart FailureMyocardial Infarction
Fondazione Don Carlo Gnocchi ETS306 enrolled6 locationsNCT07252856
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting
Phase 4

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Duk-Woo Park, MD3,320 enrolled45 locationsNCT04416581
Recruiting
Phase 1

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants

Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Phase 3

HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)

Stroke, IschemicStroke, AcuteCerebral Infarction
Weifang Medical University458 enrolled1 locationNCT07379190
Recruiting
Phase 3

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Gastrointestinal BleedingAcute Myocardial Infarction (AMI)
Samsung Medical Center5,000 enrolled1 locationNCT07467213
Recruiting
Phase 2

Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)

AphasiaAphasia Non FluentAphasia, Acquired+7 more
Teachers College, Columbia University40 enrolled1 locationNCT07036406